1. Home
  2. PM vs NVO Comparison

PM vs NVO Comparison

Compare PM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PM
  • NVO
  • Stock Information
  • Founded
  • PM 1987
  • NVO 1923
  • Country
  • PM United States
  • NVO Denmark
  • Employees
  • PM N/A
  • NVO N/A
  • Industry
  • PM Medicinal Chemicals and Botanical Products
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PM Health Care
  • NVO Health Care
  • Exchange
  • PM Nasdaq
  • NVO Nasdaq
  • Market Cap
  • PM 251.5B
  • NVO 278.0B
  • IPO Year
  • PM N/A
  • NVO N/A
  • Fundamental
  • Price
  • PM $166.10
  • NVO $54.92
  • Analyst Decision
  • PM Strong Buy
  • NVO Buy
  • Analyst Count
  • PM 12
  • NVO 7
  • Target Price
  • PM $178.25
  • NVO $98.00
  • AVG Volume (30 Days)
  • PM 5.1M
  • NVO 14.9M
  • Earning Date
  • PM 10-21-2025
  • NVO 11-05-2025
  • Dividend Yield
  • PM 3.25%
  • NVO 2.24%
  • EPS Growth
  • PM N/A
  • NVO 24.25
  • EPS
  • PM 5.27
  • NVO 3.93
  • Revenue
  • PM $39,058,000,000.00
  • NVO $49,108,936,497.00
  • Revenue This Year
  • PM $11.48
  • NVO $10.01
  • Revenue Next Year
  • PM $8.40
  • NVO $9.93
  • P/E Ratio
  • PM $31.51
  • NVO $13.90
  • Revenue Growth
  • PM 7.16
  • NVO 20.91
  • 52 Week Low
  • PM $116.12
  • NVO $45.05
  • 52 Week High
  • PM $186.69
  • NVO $138.22
  • Technical
  • Relative Strength Index (RSI)
  • PM 48.79
  • NVO 46.80
  • Support Level
  • PM $159.57
  • NVO $53.55
  • Resistance Level
  • PM $169.86
  • NVO $55.24
  • Average True Range (ATR)
  • PM 3.58
  • NVO 1.17
  • MACD
  • PM 0.27
  • NVO 0.19
  • Stochastic Oscillator
  • PM 52.79
  • NVO 39.06

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: